These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2831702)

  • 21. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
    J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of isosorbide mononitrate on hypotensive action of enalapril in patients with mild and moderate hypertension].
    Przewłocka-Kosmala M
    Pol Merkur Lekarski; 2002 Jul; 13(73):40-2. PubMed ID: 12362504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery dilation and hemodynamic responses after isosorbide dinitrate therapy in patients with coronary artery disease.
    Badger RS; Brown BG; Gallery CA; Bolson EL; Dodge HT
    Am J Cardiol; 1985 Sep; 56(7):390-5. PubMed ID: 4036818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
    Johnson G; Carson P; Francis GS; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
    Lewis BS; Hardoff R; Halon DA
    Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
    Halon DA; Rosenfeld T; Hardoff R; Lewis BS
    Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
    Alexopoulos GP; Anastasiou-Nana MI; Rapti ACh; Margari ZJ; Terrovitis JV; Mitsibounas D; Makri S; Nanas JN
    Acta Cardiol; 2003 Dec; 58(6):513-7. PubMed ID: 14713176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
    Nanas JN; Alexopoulos G; Anastasiou-Nana MI; Karidis K; Tirologos A; Zobolos S; Pirgakis V; Anthopoulos L; Sideris D; Stamatelopoulos SF; Moulopoulos SD
    J Am Coll Cardiol; 2000 Dec; 36(7):2090-5. PubMed ID: 11127445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
    Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
    Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
    Bussmann WD; Löhner J; Kaltenbach M
    Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
    Elkayam U; Amin J; Mehra A; Vasquez J; Weber L; Rahimtoola SH
    Circulation; 1990 Dec; 82(6):1954-61. PubMed ID: 2242521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.